81 – 90 of 113
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial
(
- Contribution to journal › Article
-
Mark
Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial
(
- Contribution to journal › Article
-
Mark
Genomic subtypes of breast cancer identified by array-comparative genomic hybridization display distinct molecular and clinical characteristics
(
- Contribution to journal › Article
-
Mark
High-resolution genomic and expression analyses of copy number alterations in HER2-amplified breast cancer
(
- Contribution to journal › Article
-
Mark
Identification of Subtypes in Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Reveals a Gene Signature Prognostic of Outcome.
(
- Contribution to journal › Article
-
Mark
Improving Surveillance and Quality of Life of BRCA Mutation Carriers.
(
- Contribution to journal › Article
- 2008
-
Mark
Histopathological findings and follow-up after prophylactic mastectomy and immediate breast reconstruction in 100 women from families with hereditary breast cancer.
(
- Contribution to journal › Article
- 2007
-
Mark
A hypothesis-generating search for new genetic breast cancer syndromes - a national study in 803 Swedish families
(
- Contribution to journal › Article
-
Mark
Discussion on the use of taxanes for treatment of breast cancers in BRCA1 mutations carriers
(
- Contribution to journal › Debate/Note/Editorial
- 2005
-
Mark
Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors
(
- Contribution to journal › Article